Top Story

Janssen scoops International Prix Galien for ground-breaking TB treatment

Award recognises excellence in scientific innovation to improve human health.

Read more

Investigational biologic therapy inhibits signalling of key cytokines IL-4 and IL-13....

Read more

Treatment is a once-daily, single injection fixed combination of a long-acting basal insulin...

Read more

Agreement will focus on several areas of oncology research....

Read more

Researchers at Yale and in Brazil found a case of glaucoma in an infant infected with Zika....

Read more

Free app allows users to assess risk of developing common lifestyle-driven diseases....

Read more

Decision follows positive CHMP opinion for Human Use in September 2016....

Read more

Ibrutinib is first in new class of medicines known as Bruton’s tyrosine kinase (BTK) inhibitors....

Read more

Oral cancer is on the rise for men and women, young and old....

Read more

Solanezumab failed to slow cognitive decline in people with mild Alzheimer’s disease....

Read more

Allergan acquires clinical-stage biopharmaceutical company for upfront payment of $125 million....

Read more